Last updated on November 2017

Tanezumab Chronic Low Back Pain Study

Brief description of study

Tanezumab Chronic Low Back Pain Study

Detailed Study Description

Low back pain study for people with chronic low back pain ages 18 and older. The study medication is tanezumab, a subcutaneous injection given every 8 weeks designed to relieve pain. Tanezumab will be compared to Tramadol, a drug that is approved to treat moderate to severe pain, and a placebo. A placebo looks like the study drug, but doesn’t contain any medication. At Week 16 of the study, everyone receiving placebo will be switched to tanezumab. The study lasts approximately 56 weeks with 13 office visits and 12 phone calls with study staff. All study-related medication and medical care are provided at no charge. Reimbursement may be provided for travel and other expenses related to participation. You don’t need health insurance or referrals to take part in this research study.

Clinical Study Identifier: TX7757

Contact Investigators or Research Sites near you

Start Over

Karen Towner, BSN, RN

AAIR Research Center
Rochester, NY USA